CTRI/2020/10/028568已完成2 期
Phase II, open label, randomized controlled trial to evaluate Safety and Efficacy of RV Forte Capsule as an immunomodulator in adult Covid 19 positive patients - NI
RV New Vision Healthcare Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients admitted with RT-PCR confirmed COVID-19 illness
- •Age > 18 & < 65 years of either sex
- •Mild to Moderately Covid 19 disease (NEWS score <= 8)
- •Signed informed consent must be obtained and documented according to AYUSH GCP, and
- •national/local regulations.
排除标准
- •Pregnant women
- •Breastfeeding women
- •Requiring ICU admission at screening
- •Patients above 65 years of age and below 18 Years
- •Past History of MI, Epileptic episodes
- •Any other co-morbidity (uncontrolled diabetes, severe hypertension from subject history) which
- •is at critical stage at screening
- •Any other condition by which subject proves unfit from investigator perspective
- •Not giving consent.
研究者
相似试验
尚未招募
2 期
Clinical trial of ShatPlus as an immunomodulator in adult Covid 19 positive patientsCTRI/2020/06/025999BVG Life Sciences Ltd
招募中
2 期
Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid 19 patientsCTRI/2020/07/026630Mr Ghanshyam Goti
尚未招募
2 期
Clinical trial of herbal supplement as an immunomodulator in adult Covid 19 positive patients.CTRI/2020/06/026187Mr Ghanshyam Goti
进行中（未招募）
1 期
A randomized clinical study to investigate the efficiency of a novel anti-cancer medication against neuroblastoma in children, adolescent and young adults in whom the tumor relapsed or was refractory to standard careRelapsed or refractory high risk neuroblastomaEUCTR2011-004062-15-DEniversity Hospital of Regensburg114
进行中（未招募）
1 期
A randomized clinical study to investigate the efficiency of a novel anti-cancer medication against neuroblastoma in children, adolescent and young adults in whom the tumor relapsed or was refractory to standard care.Relapsed or refractory high risk neuroblastomaEUCTR2011-004062-15-ATniversity Hospital of Regensburg114